BACKGROUND: Toxoplasma gondii (T. gondii) is a neurotropic protozoan parasite that causes persistent infection in humans. A substantial literature suggests that schizophrenia is associated with increased seroprevalence of T. gondii, but a possible link of the parasite with mood disorders has not been as thoroughly investigated. METHODS: We examined the association of Toxoplasma-specific immunoglobulin G results with mood disorder outcomes in 7440 respondents from the third National Health and Nutrition Survey, which is a nationally representative sample of the United States noninstitutionalized civilian population. Regression models were adjusted for numerous potential confounders, including tobacco smoking and C-reactive protein levels. RESULTS: No statistically significant associations were found between T. gondii seroprevalence and a history of major depression (n = 574; adjusted odds ratio [OR]: .8; 95% confidence interval [CI]: .5-1.2), severe major depression (n = 515; adjusted OR: .8; 95% CI: .6-1.2), dysthymia (n = 548; adjusted OR: 1.1; 95% CI: .7-1.8), or dysthymia with comorbid major depression (n = 242, adjusted OR: 1.2; 95% CI: .6-2.4), all p values were > .05, including analysis stratified by gender. However, there was a significant relationship between T. gondii seroprevalence and bipolar disorder type I for respondents in which both manic and major depression symptoms were reported (n = 41; adjusted OR: 2.4; 95% CI: 1.2-4.8; p < .05). CONCLUSIONS: In a population-based sample, T. gondii seroprevalence is not elevated in unipolar mood disorders but is higher in a subset of respondents with a history of bipolar disorder type 1.
BACKGROUND:Toxoplasma gondii (T. gondii) is a neurotropic protozoan parasite that causes persistent infection in humans. A substantial literature suggests that schizophrenia is associated with increased seroprevalence of T. gondii, but a possible link of the parasite with mood disorders has not been as thoroughly investigated. METHODS: We examined the association of Toxoplasma-specific immunoglobulin G results with mood disorder outcomes in 7440 respondents from the third National Health and Nutrition Survey, which is a nationally representative sample of the United States noninstitutionalized civilian population. Regression models were adjusted for numerous potential confounders, including tobacco smoking and C-reactive protein levels. RESULTS: No statistically significant associations were found between T. gondii seroprevalence and a history of major depression (n = 574; adjusted odds ratio [OR]: .8; 95% confidence interval [CI]: .5-1.2), severe major depression (n = 515; adjusted OR: .8; 95% CI: .6-1.2), dysthymia (n = 548; adjusted OR: 1.1; 95% CI: .7-1.8), or dysthymia with comorbid major depression (n = 242, adjusted OR: 1.2; 95% CI: .6-2.4), all p values were > .05, including analysis stratified by gender. However, there was a significant relationship between T. gondii seroprevalence and bipolar disorder type I for respondents in which both manic and major depression symptoms were reported (n = 41; adjusted OR: 2.4; 95% CI: 1.2-4.8; p < .05). CONCLUSIONS: In a population-based sample, T. gondii seroprevalence is not elevated in unipolar mood disorders but is higher in a subset of respondents with a history of bipolar disorder type 1.
Authors: Jianchun Xiao; Stephen L Buka; Tyrone D Cannon; Yasuhiro Suzuki; Raphael P Viscidi; E Fuller Torrey; Robert H Yolken Journal: Microbes Infect Date: 2009-07-26 Impact factor: 2.700
Authors: Emese Prandovszky; Elizabeth Gaskell; Heather Martin; J P Dubey; Joanne P Webster; Glenn A McConkey Journal: PLoS One Date: 2011-09-21 Impact factor: 3.240
Authors: Alessandra F Gomes; Erick V Guimarães; Laís Carvalho; José R Correa; Leila Mendonça-Lima; Helene S Barbosa Journal: BMC Microbiol Date: 2011-05-18 Impact factor: 3.605
Authors: Jaana Suvisaari; Minna Torniainen-Holm; Maija Lindgren; Tommi Härkänen; Robert H Yolken Journal: J Affect Disord Date: 2017-07-10 Impact factor: 4.839
Authors: Abhishek Wadhawan; Aline Dagdag; Allyson Duffy; Melanie L Daue; Kathy A Ryan; Lisa A Brenner; John W Stiller; Toni I Pollin; Maureen W Groer; Xuemei Huang; Christopher A Lowry; Braxton D Mitchell; Teodor T Postolache Journal: Pteridines Date: 2017-11-22 Impact factor: 0.581
Authors: Zaki Ahmad; Yara W Moustafa; John W Stiller; Mary A Pavlovich; Uttam K Raheja; Claudia Gragnoli; Soren Snitker; Sarra Nazem; Aline Dagdag; Beverly Fang; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache Journal: Pteridines Date: 2017-11-28 Impact factor: 0.581
Authors: Ashwin Jacob Mathai; Christopher A Lowry; Thomas B Cook; Lisa A Brenner; Lena Brundin; Maureen W Groer; Xiaoqing Peng; Ina Giegling; Annette M Hartmann; Bettina Konte; Marion Friedl; Dietmar Fuchs; Dan Rujescu; Teodor T Postolache Journal: Pteridines Date: 2016-10-21 Impact factor: 0.581